Literature DB >> 11511108

Potent and selective peptide agonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro.

M A Bednarek1, T MacNeil, R Tang, R N Kalyani, L H Van der Ploeg, D H Weinberg.   

Abstract

alpha-Melanotropin (alphaMSH) and several of its derivatives are potent but not selective agonists at melanocortin receptors 3, 4, and 5 present in the brain (MC3-5R). To differentiate between the physiological role of hMC-4R (believed to be involved in regulation of energy balance) from those of melanocortin receptors 3 and 5, potent and receptor-specific agonists are needed. Therefore, the cyclic derivatives of alphaMSH of a general structure, cyclo(X-His-d-Phe-Arg-Trp-Y)-NH(2), where X is succinic acid or an omega-amino-carboxylic acid, and Y is an alpha,omega-di-amino-carboxylic acid or an omega-carboxy-alpha-amino acid, were prepared and tested in binding assays and in cAMP assays on CHO cells expressing hMC3-5R. Several of the 21-membered or larger lactams turned out to be potent and hMC-4R-selective agonists. For instance, cyclo(CO-CH(2)-CH(2)-CO-His-d-Phe-Arg-Trp-Dab)-NH(2) (Dab: 2,4-di-amino-butyric acid) was a potent agonist at hMC-4R (EC(50) = 4 nM) with 55-fold selectivity over hMC-3R and greater than 1000-fold selectivity over hMC-5R. Another potent and selective compound was cyclo(NH-CH(2)-CH(2)-CO-His-d-Phe-Arg-Trp-Glu)-NH(2): EC(50) about 1 nM at hMC-4R, with 90-fold selectivity over hMC-3R and greater than 2000-fold selectivity over hMC-5R. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511108     DOI: 10.1006/bbrc.2001.5444

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Melanocortinergic control of penile erection.

Authors:  H Wessells; J E Blevins; T W Vanderah
Journal:  Peptides       Date:  2005-10       Impact factor: 3.750

2.  Effects of macrocycle size and rigidity on melanocortin receptor-1 and -5 selectivity in cyclic lactam alpha-melanocyte-stimulating hormone analogs.

Authors:  Alexander V Mayorov; So-Yeop Han; Minying Cai; Matthew R Hammer; Dev Trivedi; Victor J Hruby
Journal:  Chem Biol Drug Des       Date:  2006-05       Impact factor: 2.817

3.  Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities.

Authors:  Alexander V Mayorov; Minying Cai; Kevin B Chandler; Ravil R Petrov; April R Van Scoy; Zerui Yu; Dustin K Tanaka; Dev Trivedi; Victor J Hruby
Journal:  J Med Chem       Date:  2006-03-23       Impact factor: 7.446

4.  Characterization of a novel melanocortin receptor-containing node in the SNS outflow circuitry to brown adipose tissue involved in thermogenesis.

Authors:  C H Vaughan; Y B Shrestha; T J Bartness
Journal:  Brain Res       Date:  2011-07-13       Impact factor: 3.252

5.  Structure-activity relationships of peptides incorporating a bioactive reverse-turn heterocycle at the melanocortin receptors: identification of a 5800-fold mouse melanocortin-3 receptor (mMC3R) selective antagonist/partial agonist versus the mouse melanocortin-4 receptor (mMC4R).

Authors:  Anamika Singh; Marvin Dirain; Rachel Witek; James R Rocca; Arthur S Edison; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2013-03-25       Impact factor: 7.446

6.  Melanocortins and agouti-related protein modulate the excitability of two arcuate nucleus neuron populations by alteration of resting potassium conductances.

Authors:  Mark A Smith; Kazunari Hisadome; Hind Al-Qassab; Helen Heffron; Dominic J Withers; Michael L J Ashford
Journal:  J Physiol       Date:  2006-10-26       Impact factor: 5.182

7.  MC4-R signaling within the nucleus accumbens shell, but not the lateral hypothalamus, modulates ethanol palatability in rats.

Authors:  Jose M Lerma-Cabrera; Francisca Carvajal; Gabriela Chotro; Mirari Gaztañaga; Montserrat Navarro; Todd E Thiele; Inmaculada Cubero
Journal:  Behav Brain Res       Date:  2012-11-09       Impact factor: 3.332

8.  Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice.

Authors:  Bassil M Kublaoui; Terry Gemelli; Kristen P Tolson; Yu Wang; Andrew R Zinn
Journal:  Mol Endocrinol       Date:  2008-05-01

9.  Further structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5.

Authors:  Paolo Grieco; Minying Cai; Guoxia Han; Dev Trivedi; Pietro Campiglia; Ettore Novellino; Victor J Hruby
Journal:  Peptides       Date:  2007-03-01       Impact factor: 3.750

10.  Contribution of regional brain melanocortin receptor subtypes to elevated activity energy expenditure in lean, active rats.

Authors:  C Shukla; L G Koch; S L Britton; M Cai; V J Hruby; M Bednarek; C M Novak
Journal:  Neuroscience       Date:  2015-09-25       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.